Ligand validation:5QF2

JMA: 4-(5,6-dichloro-1H-benzimidazol-1-yl)butan-1-ol

JMA is a Ligand Of Interest in 5QF2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QF2_JMA_A_401	4%	23%	0.35	0.72	2.19	1.15	5	1	0	0	100%	0.2

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.